168 related articles for article (PubMed ID: 3331653)
1. Thymopentin (TP-5) therapy during lymphadenopathy syndrome (LAS/ARC): preliminary report.
Costigliola P; Ricchi E; Colangeli V; Pintori C; Boni P; Chiodo F
J Exp Pathol; 1987; 3(4):705-12. PubMed ID: 3331653
[TBL] [Abstract][Full Text] [Related]
2. Preliminary results on clinical and immunological effects of thymopentin in AIDS.
Clumeck N; van de Perre P; Mascart-Lemone F; Cran S; Bolla K; Duchateau J
Int J Clin Pharmacol Res; 1984; 4(6):459-63. PubMed ID: 6398315
[TBL] [Abstract][Full Text] [Related]
3. Thymopentin (TP-5) in the treatment of the postburn and postoperative immunodeficiency syndrome.
Hamilton G; Zöch G; Rath T; Meissl G
Prog Clin Biol Res; 1989; 308():995-9. PubMed ID: 2528748
[No Abstract] [Full Text] [Related]
4. [Thymopentin and immune response in patients with cancer].
Petronella P; Ferrone R; Freda F; Valeriani G
Minerva Chir; 1989 Sep; 44(18):2017-20. PubMed ID: 2694011
[TBL] [Abstract][Full Text] [Related]
5. Immunologic effects of long-term thymopentin treatment in patients with HIV-induced lymphadenopathy syndrome.
Silvestris F; Gernone A; Frassanito MA; Dammacco F
J Lab Clin Med; 1989 Feb; 113(2):139-44. PubMed ID: 2644387
[TBL] [Abstract][Full Text] [Related]
6. Thymopentin in chronic Trichophyton rubrum infection.
Molin L; Bolla K
Surv Immunol Res; 1985; 4 Suppl 1():135-8. PubMed ID: 3898286
[TBL] [Abstract][Full Text] [Related]
7. Experiences with immunomodulant agents in HIV infections.
Lazzarin A; Barcellini W; Uberti Foppa C; Borghi MO; Franzetti R; Cinque P; Moroni M
Acta Haematol; 1987; 78 Suppl 1():84-90. PubMed ID: 3124453
[TBL] [Abstract][Full Text] [Related]
8. Effect of subcutaneous thymopentin treatment in drug addicts with persistent generalized lymphadenopathy.
Barcellini W; Meroni PL; Frasca D; Sguotti C; Borghi MO; Uberti-Foppa C; Buzzetti P; Lazzarin A; Doria G; Moroni M
Clin Exp Immunol; 1987 Mar; 67(3):537-43. PubMed ID: 3301099
[TBL] [Abstract][Full Text] [Related]
9. Thymopentine treatment improves clinical and immunological functions in aged subjects with chronic bronchitis.
Pavoni D; Crosti F; Ciboddo GF; Sabbadini MG; Baldini V; Navone P; Bellone M; Rugarli C
Boll Ist Sieroter Milan; 1987; 66(4):308-15. PubMed ID: 3327513
[TBL] [Abstract][Full Text] [Related]
10. [Thymopentin treatment of ovarian carcinoma: preliminary clinical results].
Garozzo G; Granà G; Lomeo E; La Greca M; Castiglione MG; Caruso M; Curatolo M; Gurgone P
G Ital Oncol; 1988; 8(1):11-3. PubMed ID: 3065223
[No Abstract] [Full Text] [Related]
11. Thymopentin treatment of herpes simplex infections. An open, monitored, multicenter study.
DeMaubeuge J; Haneke E; Djawari D; Wolff K; Stingl G; Molin L; Schöpf E; Stengel R; Degreef H; Panconesi E
Surv Immunol Res; 1985; 4 Suppl 1():30-6. PubMed ID: 2863860
[TBL] [Abstract][Full Text] [Related]
12. [A case of juvenile rheumatoid arthritis treated with thymopentin].
Tucciarone L; Felici W; Greco L; Mechelli A
Minerva Pediatr; 1989 Feb; 41(2):109-11. PubMed ID: 2661988
[TBL] [Abstract][Full Text] [Related]
13. Thymopentin in the treatment of alopecia areata.
Orecchia G
Dermatologica; 1989; 178(4):231. PubMed ID: 2670621
[No Abstract] [Full Text] [Related]
14. [Immunomodulating therapy in chronic polyarthritis with thymopentin. A multicenter placebo-controlled study of 119 patients].
Lemmel EM; Bach GL; Bolten W; Brackertz D; Fahmy Z; Mattern H; Stroehmann I; Wittenborg A
Dtsch Med Wochenschr; 1988 Feb; 113(5):172-6. PubMed ID: 3276492
[TBL] [Abstract][Full Text] [Related]
15. [Thymopentin in a case of autoimmune thrombocytopenia secondary to chronic lymphatic leukemia].
Cantore M; Bucalossi A; Butini P; Carnevali A; Cavion MA; Leoncini L
G Clin Med; 1989; 70(6-7):421, 423, 425. PubMed ID: 2670653
[TBL] [Abstract][Full Text] [Related]
16. Influence of thymopentin on postsurgical immune deficiency: a clinical pilot study.
Faist E; Riedel A; Bolla K
Int J Clin Pharmacol Res; 1987; 7(1):83-7. PubMed ID: 3294617
[TBL] [Abstract][Full Text] [Related]
17. Improvement of natural killer activity and of T cells after thymopoietin pentapeptide therapy in a patient with severe combined immunodeficiency.
Fiorilli M; Sirianni MC; Pandolfi F; Quinti I; Tosti U; Aiuti F; Goldstein G
Clin Exp Immunol; 1981 Aug; 45(2):344-51. PubMed ID: 7032772
[TBL] [Abstract][Full Text] [Related]
18. Thymopentin in active rheumatoid arthritis. An open, monitored study in 16 patients.
Franchimont P; Hauwaert C; Bolla K
Surv Immunol Res; 1985; 4 Suppl 1():81-6. PubMed ID: 3898297
[TBL] [Abstract][Full Text] [Related]
19. Thymopentin in dermatology.
Haneke E
Curr Probl Dermatol; 1989; 18():283-9. PubMed ID: 2663371
[No Abstract] [Full Text] [Related]
20. [Thymopentin in the treatment of recurrent condylomata acuminata].
Ghetti P; Negosanti M; Andriani GC; Beltrandi E; Maldini M
Minerva Ginecol; 1989 Feb; 41(2):113-6. PubMed ID: 2664577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
